[1]
“Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs”, Reumatismo, vol. 66, no. 3, pp. 208–214, Nov. 2014, doi: 10.4081/reumatismo.2014.756.